332
Views
15
CrossRef citations to date
0
Altmetric
AUDIOLOGY

Water-soluble coenzyme Q10 formulation (Q-TER®) in the treatment of presbycusis

, , , , , & show all
Pages 1154-1162 | Received 30 Dec 2009, Accepted 22 Feb 2010, Published online: 05 May 2010

References

  • Kalivas PW, O'Brien C. Drug addition as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008;33:166–80.
  • Lloyd GK, Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther 2000;292:461–7.
  • Remenyi J, Marshall A, Enticott JC, Briggs RJS. The prognostic value of speech recognition scores at diagnosis of vestibular schwannoma. J Clin Neurosci 2009;16:1460–3.
  • Fetoni AR, Garzaro M, Ralli G, Landolfo V, Sensini M, Pecorari G, The monitoring role of otoacoustic emissions and oxidative stress markers in the protective effects of antioxidant administration in noise-exposed subjects: a pilot study. Med Sci Monit 2009;15:PR1–8.
  • Cadoni G, Scipione S, Agostino S, Addolorato G, Cianfrone F, Leggio L, Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients. Otol Neurotol 2007;28:878–83.
  • Bao J, Lei D, Du Y, Ohlemiller KK, Beaudet AL, Role LW. Requirement of nicotinic acetylcholine receptor subunit β2 in the maintenance of spiral ganglion neurons during aging. J Neurosci 2005;25:3041–5.
  • Ohlemiller KK, Gagnon PM. Apical-to-basal gradients in age-related cochlear degeneration and their relationship to “primary” loss of cochlea neurons. J Comp Neurol 2004;479:103–16.
  • McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995;57:521–46.
  • Lloyd GK, Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther 2000;292:461–7.
  • Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004;74:363–96.
  • Belluardo N, Mudo G, Blum M, Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res 2000;113:21–34.
  • Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001;11:272–80.
  • Garrido R, Mattson MP, Hennig B, Toborek M. Nicotine protects against arachidonic-acid-induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons. J Neurochem 2001;76:1395–403.
  • Krajewski S, Krajewska M, Ellerby LM, Reed JC. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA 1999;96:5752–7.
  • Fetoni AR, Piacentini R, Fiorita A, Paludetti G, Troiani D. Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res 2009;1257:108–16.
  • Hirose Y, Sugahara K, Mikuriya T, Hashimoto M, Shimogori H, Yamashita H. Effect of water-soluble coenzyme Q10 on noise-induced hearing loss in guinea pigs. Acta Otolaryngol 2008;128:1071-6.
  • Kalayam B, Meyers BS, Kakuma T, Alexopoulos GS, Young RC, Solomon S, Age at onset of geriatric depression and sensorineural hearing deficits. Biol Psychiatry 1995;38:649–58.
  • Sandhu JK, Pandey S, Ribecco-Lutkiewicz M, Monette R, Borowy-Borowski H, Walker PR, Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q10. J Neurosci Res 2003;72:691–703.
  • Gonzalez-Perez O, Gonzalez-Castañeda RE, Huerta M, Luquin S, Gomez-Pinedo U, Sanchez-Almaraz E, Beneficial effects of alpha-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain. Neurosci Lett 2002;321:100–4.
  • Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. Safety assessment of coenzyme Q10 (CoQ10). Biofactors 2008;32:199–208.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.